OPTIMIZATION OF THE PHARMACOKINETIC (PK) AND PHARMACODYNAMIC (PD) PROPERTIES OF AN ANTI-ABETA ANTIBODY M266 FAB FRAGMENT VARIANT BY SITE-SPECIFIC PEGYLATION

Saved in:
Bibliographic Details
Published inAlzheimer's & dementia Vol. 12; no. 7; p. P433
Main Authors Racke, Margaret M, Day, Theresa A, Hole, Justin T, Chow, Chi-Kin, Lu, Jirong, DeMattos, Ronald B
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.07.2016
Subjects
Neurology
Online AccessGet full text

Cover

More Information
ISSN:1552-5260
1552-5279
DOI:10.1016/j.jalz.2016.06.829